NetworkNewsBreaks

WednesdayDec 09, 2020 10:02 am

NetworkNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Announces LOI with Owner of PURICA(TM) Brand of Wellness Product

Pure Extracts Technologies (CSE: PULL), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sector, recently signed a letter of intent with the Nutraceutical Medicine Company Inc. (“PURICA”). PURICA owns and distributes the PURICA product line of full-spectrum, mushroom-derived wellness products. Pure Extracts anticipates the PURICA brand will support PULL’s expansion into the functional mushroom sector. For the past two decades, PURICA has offered natural and whole food products that are backed by science. The company’s Immune 7 formulation has been the Alive Award gold winner for the best immunity product in Canada two years in a…

Continue Reading

TuesdayDec 08, 2020 3:07 pm

NetworkNewsBreaks – PlantX Life Inc. (CSE: VEGA) (OTC: PLTXF) (Frankfurt: WNT1) Announces Commencement of OTC Trading, Grant of Stock Options, RSU and PSU Plans

PlantX (CSE: VEGA) (OTC: PLTXF) (Frankfurt: WNT1) recently announced that its common shares have begun trading on the OTC Pink Market under the symbol “PLTXF.” The company also announced that, per the terms and conditions of its incentive stock option plan, PlantX has granted 1,815,000 incentive stock options to purchase common shares of PlantX to certain executive officers, consultants and employees of the company. The options are exercisable for a five-year period at a price of $0.70 per share. In addition, as part of a new long-term incentive program, PlantX announced approval by its board of directors, subject to regulatory…

Continue Reading

TuesdayDec 08, 2020 2:38 pm

NetworkNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Stands Distinct Among Many Peers, Public Companies with Debt-Free Status

Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading producer of uranium in the United States, recently announced a corporate update and financial results for the quarter ended Sept. 30, 2020 (https://nnw.fm/elLXK ). In addition to being debt free, Energy Fuels had working capital of $44.7 million at the end of Q3 2020, which is a 17% increase over Q2 2020. An article discussing Energy Fuels’ ability to achieve a debt-free status quotes the company’s president and CEO Mark S. Chalmers, who stated, “While many uranium and other natural resource companies have significant debt burdens, Energy Fuels is proud to announce…

Continue Reading

TuesdayDec 08, 2020 2:25 pm

NetworkNewsBreaks – Friendable Inc.’s (FDBL) Fan Pass Creates ‘Hybrid’ Model for Virtual Performances Around the World

Friendable (OTC: FDBL), a mobile technology and marketing company that leverages proprietary applications to connect and engage users, has achieved record increases in new artists to its live streaming platform. Fan Pass, the company’s flagship product, provides exclusive content channels, live streaming events, promotional support, fan subscriptions and custom merchandise designs for artists at all levels, assisting them to build new revenue streams. “As the uncertainty continues around live venues and performances, we feel even stronger demand from artists seeking the foundational elements of performing from the virtual stage,” said Friendable CEO Robert A. Rositano Jr. “No matter how the…

Continue Reading

TuesdayDec 08, 2020 2:16 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Shines Spotlight on Clinical Design for Upcoming Phase 2 Trial

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, is advancing a drug candidate it hopes will beat the deadly brain cancer Glioblastoma Multiforme (“GBM”). The company recently announced that its submission of an Investigational New Drug (“IND”) application to the U.S. Food & Drug Administration (“FDA”) has been accepted for review and discussed a novel clinical design for its upcoming Phase 2 U.S. trial in a webinar open to the public. “I would like to remind everyone that this upcoming Phase 2…

Continue Reading

TuesdayDec 08, 2020 2:14 pm

NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Announces Launch of Trxade Prime Purchasing Solution

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced the launch of Trxade Prime, a revolutionary service offered by the company's Integra Pharma Solutions subsidiary. According to the update, Trxade Prime solves a historic problem for independent pharmacies suffering from an already complex prescription distribution process. The solution allows Trxade platform independent pharmacy members to process, consolidate and ship purchase orders placed directly with Trxade Suppliers via the Trxade Prime service. “The mission of Trxade, from its inception, has been to empower and encourage growth within the independent pharmacy community,” said Trxade Group CEO…

Continue Reading

TuesdayDec 08, 2020 2:00 pm

NetworkNewsBreaks – Predictive Oncology Inc.’s (NASDAQ: POAI) Soluble Biotech Solution Shaves Time, Money to Optimize Therapeutic Formulations

Predictive Oncology (NASDAQ: POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (“AI”) to personalized medicine and drug discovery. Through its subsidiary Soluble Biotech, the company delivers a solution that reduces the cost, time and manpower needed to optimize therapeutic formulations. A recent article discussing this reads, “HSC Technology is a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens, using additives and excipients commonly included in protein formulations (https://nnw.fm/xXNvl). The data generated from these screens is analyzed by a predictive algorithm used to identify the optimal combination of additives and excipients, resulting in increased…

Continue Reading

TuesdayDec 08, 2020 1:49 pm

NetworkNewsBreaks – HempFusion Wellness Inc. Building Presence in Budding Marketplace

HempFusion Wellness, a leader in the health and wellness cannabidiol (“CBD”) industry, is making strategic moves in a sector that seems to have transcended the upheaval that has defined 2020. The recent U.S. election demonstrated the lasting potential of the market for cannabis-derived products when five states joined the march toward legalizing marijuana for recreational or medicinal uses (https://nnw.fm/41UKq). An article discussing the company reads, “Denver-based HempFusion Wellness has continued to build its own movement toward market success in the cannabis wellness industry, developing 46 products that are currently on shelves while establishing the second-largest cash position in its sector…

Continue Reading

TuesdayDec 08, 2020 12:52 pm

NetworkNewsBreaks – Grey Cloak Tech Inc. (GRCK) Announces Impressive Study Results for Fuel4Thought(TM) Brain Booster

Grey Cloak Tech (OTCQB: GRCK) (soon to be Healthy Extracts Inc.), a company engaged in proprietary development of natural plant-based formulations and sales and distribution of cardiovascular and neuro products, today announced that its subsidiary, Ultimate Brain Nutrients(TM), ( “UBN” ) has released its study of Fuel4Thought(TM) Brain Booster (“F4T(TM)”). According to the update, the study demonstrates impressive results in brain activation, sports vision, hand-to-eye coordination and auditory reaction time. “Fuel4Thought(TM) is one of the main reasons we acquired Ultimate Brain Nutrients(TM),” said GRCK President Duke Pitts. “F4T(TM) Brain Booster is the first of three amazing products we will be…

Continue Reading

TuesdayDec 08, 2020 12:27 pm

NetworkNewsBreaks – Way2Grow (‘W2G’) Biopharma Company Secures Health Canada Approval for Standard Cultivation, Processing, Medical Sales

Way2Grow Nurseries (“Way2Grow” or “W2G”), a privately owned biopharma company, today announced its receipt of Health Canada’s approval for the standard cultivation, standard processing and sale for medical purposes under the Cannabis Regulations. According to the update, the licenses are effective as of Nov. 20, 2020. Valid for a three-year period, the terms of the licenses include approval of a single-story production facility designed to support micropropagation tissue culture, organic cultivation, processing and medical sales requirements. Phase II plans include expansion of the research laboratory and controlled cultivation rooms, as well as the addition of a medical dispensary. To view…

Continue Reading